Product
VRC-FLUNPF099-00-VP
1 clinical trial
1 indication
Indication
InfluenzaClinical trial
A Phase 1, Open-Label, Comparator-Controlled, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of a Single Dose of VRC H1ssF-3928 mRNA-LNP in Healthy AdultsStatus: Recruiting, Estimated PCD: 2025-08-20